Marine E. Gasparian
16/10 Miklukho Maklaya St
Moscow, MOW 117997, Russian Federation
Moscow, MOW 117997, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Long-Term Culture of U87MG Glioblastoma Cells Reprograms Metabolism, Impacts Aggressiveness and Alters Drug Responses.
Journal: Cell biochemistry and biophysics
Published: July 05, 2026
Codelivery of Bortezomib and Modified DR5-Selective TRAIL via Amphiphilic Poly(N-vinylpyrrolidone) Bionanocomposites to Overcome Glioblastoma Resistance.
Journal: ACS applied bio materials
Published: November 24, 2025
Amphiphilic Poly(N-vinylpyrrolidone) Biocomposites with Bortezomib and DR5-Selective TRAIL Variants: A Promising Approach to Pancreatic Cancer Treatment.
Journal: International journal of molecular sciences
Published: October 17, 2025
Synergistic effect of DR5-targeted capsules loaded with doxorubicin in drug-resistant 3D tumour spheroids.
Journal: Journal of microencapsulation
Published: October 14, 2025
Senolytic Properties of DR5-Selective TRAIL in Pancreatic Cancer Cell Lines.
Journal: Acta naturae
Published: October 10, 2025
Novel Fusion Protein Based on DR5-Specific TRAIL Variant with Enhanced Antitumor Properties.
Journal: Biochemistry. Biokhimiia
Published: October 09, 2025
Assessment of the angiogenic potential of xenografted tumors by biomedical imaging techniques.
Journal: Biomedical optics express
Published: September 04, 2025
Temozolomide-induced senescent glioblastoma cells acquire sensitivity to TRAIL death receptor 5-mediated apoptosis.
Journal: Medical oncology (Northwood, London, England)
Published: July 04, 2025
Multivalent fusion protein targeting VEGFR2 and DR5 receptors: assessing the antiangiogenic and antitumor effects via multimodal microangiography.
Journal: Journal of translational medicine
Published: February 28, 2025
Glioblastoma Sensitization to Therapeutic Effects by Glutamine Deprivation Depends on Cellular Phenotype and Metabolism.
Journal: Biochemistry. Biokhimiia
Published: November 10, 2024
Correction: Yagolovich et al. DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma. Int. J. Mol. Sci. 2022, 23, 12687.
Journal: International journal of molecular sciences
Published: April 22, 2024
Toxicity Evaluation and Controlled-Release of Curcumin-Loaded Amphiphilic Poly-N-vinylpyrrolidone Nanoparticles: In Vitro and In Vivo Models.
Journal: Pharmaceutics
Published: November 20, 2023
Last Updated: 09/26/2026